Literature DB >> 2871885

Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices.

H F Bradford, J M Crowder, E J White.   

Abstract

The effects of opioid agonists on veratrine-stimulated Ca2+ influx and amino acid neurotransmitter release in rat cerebrocortical brain slices were studied. Inhibitory effects were seen on both of these parameters with all of the opioid agonists used. None of the drugs used affected basal 45Ca2+ uptake, basal K+ content or basal amino acid release from the slices. At high concentrations (100 microM) fentanyl, tifluadom, U50,488H, butorphanol and bremazocine greatly inhibited the depolarization of the slices by veratrine as determined by the reduced release of K+. The opioid receptor subtypes at which the drugs were acting were characterized by the antagonistic effects of naloxone and WIN44441-3. The opioid-induced inhibition of stimulated Ca2+ uptake and amino acid release were not antagonized by WIN44441-2, the inactive enantiomer of WIN44441-3. It is concluded that opioid agonists acting through mu- and kappa-receptors and probably through delta- and sigma-receptors, have an inhibitory effect on Ca2+ uptake into cerebrocortical brain slices and the subsequent release of aspartate, glutamate and gamma-aminobutyric acid (GABA).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871885      PMCID: PMC1917116          DOI: 10.1111/j.1476-5381.1986.tb09474.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Techniques in tissue metabolism. 5. Chopping and slicing tissue samples.

Authors:  H MCILWAIN
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

2.  Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.

Authors:  K J Chang; B R Cooper; E Hazum; P Cuatrecasas
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

3.  Stimulated incorporation of amino acids into proteins of synaptosomal fractions induced by depolarizing treatments.

Authors:  E Wedege; Y Luqmani; H F Bradford
Journal:  J Neurochem       Date:  1977-09       Impact factor: 5.372

4.  Neurotransmitters decrease the calcium ocmponent of sensory neurone action potentials.

Authors:  K Dunlap; G D Fischbach
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

5.  Inhibition of depolarization-coupled calcium fluxes and transmitter release in vitro by morphine.

Authors:  D Dhaliwal; H F Bradford
Journal:  FEBS Lett       Date:  1982-07-19       Impact factor: 4.124

6.  Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects.

Authors:  R R Goodman; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Bremazocine: a potent, long-acting opiate kappa-agonist.

Authors:  D Römer; H Büscher; R C Hill; R Maurer; T J Petcher; H B Welle; H C Bakel; A M Akkerman
Journal:  Life Sci       Date:  1980-09-15       Impact factor: 5.037

8.  An opioid benzodiazepine.

Authors:  D Römer; H H Büscher; R C Hill; R Maurer; T J Petcher; H Zeugner; W Benson; E Finner; W Milkowski; P W Thies
Journal:  Nature       Date:  1982-08-19       Impact factor: 49.962

9.  Effects of (D-alanine2, methionine5) enkephalinamide on the release of acetylcholine and noradrenaline from brain slices and isolated nerve terminals.

Authors:  C A Jones; R M Marchbanks
Journal:  Biochem Pharmacol       Date:  1982-02-01       Impact factor: 5.858

10.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film.

Authors:  R Quirion; R P Hammer; M Herkenham; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  9 in total

1.  Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

Authors:  J M Hiller; L Q Fan
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

2.  Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia.

Authors:  Li Yang; Kaushik Shah; Hezhen Wang; Vardan T Karamyan; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2011-08-19       Impact factor: 4.030

Review 3.  Mechanisms of ischemic brain damage.

Authors:  Anish Bhardwaj; Nabil J Alkayed; Jeffrey R Kirsch; Patricia D Hurn
Journal:  Curr Cardiol Rep       Date:  2003-03       Impact factor: 2.931

4.  Kappa Opioid Receptor Agonist and Brain Ischemia.

Authors:  Chen Chunhua; Xi Chunhua; Sugita Megumi; Liu Renyu
Journal:  Transl Perioper Pain Med       Date:  2014

Review 5.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

6.  Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.

Authors:  Pei-Lan Zhou; Yu-Lei Li; Ling-Di Yan; Zheng Yong; Gang Yu; Hua-Jin Dong; Hui Yan; Rui-Bin Su; Ze-Hui Gong
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  Effects of the Hybridization of Opioid and Neurotensin Pharmacophores on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Patrycja Kleczkowska; Maria Kawalec; Magdalena Bujalska-Zadrozny; Małgorzata Filip; Barbara Zablocka; Andrzej W Lipkowski
Journal:  Neurotox Res       Date:  2015-08-19       Impact factor: 3.911

8.  In vivo morphine decreases [3H]nimodipine receptor binding in rat brain regions.

Authors:  V C Gandhi; D H Ross
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

9.  Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats.

Authors:  Dinesh K Dhull; Anil Kumar
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.